ERRATUM article

Front. Pharmacol., 16 September 2022

Sec. Experimental Pharmacology and Drug Discovery

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1027099

Erratum: Remdesivir strongly binds to RNA-dependent RNA polymerase, membrane protein, and main protease of SARS-CoV-2: Indication from molecular modeling and simulations

  • FP

    Frontiers Production Office *

  • Frontiers Media SA, Lausanne, Switzerland

Due to a production error, the figures were incorrectly matched with their captions in the final published article. The correct figures and captions appear below.

The publisher apologizes for this mistake. The original version of this article has been updated.

FIGURE 1

FIGURE 2

FIGURE 3

FIGURE 4

FIGURE 5

FIGURE 6

FIGURE 7

FIGURE 8

FIGURE 9

FIGURE 10

FIGURE 11

Summary

Keywords

SARS-CoV-2, remdesivir, main protease, membrane proteins, RNA-dependent RNA polymerase

Citation

Frontiers Production Office (2022) Erratum: Remdesivir strongly binds to RNA-dependent RNA polymerase, membrane protein, and main protease of SARS-CoV-2: Indication from molecular modeling and simulations. Front. Pharmacol. 13:1027099. doi: 10.3389/fphar.2022.1027099

Received

24 August 2022

Accepted

24 August 2022

Published

16 September 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Frontiers Production Office,

This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics